<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02834169</url>
  </required_header>
  <id_info>
    <org_study_id>69HCL16_0406</org_study_id>
    <nct_id>NCT02834169</nct_id>
  </id_info>
  <brief_title>French National Registry of Rare Peritoneal Surface Malignancies</brief_title>
  <acronym>RENAPE</acronym>
  <official_title>French National Registry of Rare Peritoneal Surface Malignancies (RENAPE Registry)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Despite advances in the management of and changes in clinical practice, little is known about
      the epidemiology, patterns of care and outcomes of rare peritoneal surface malignancies
      patients in France.

      In order to better understand the characteristics of rare peritoneal surface malignancies and
      to evaluate treatment strategies, the RENAPE registry aims at the collection of data from
      patients presenting with a rare peritoneal surface malignancy in France. Data will be entered
      prospectively in a specifically designed and secured web database.

      All RENAPE's centres and physicians are invited to register patients with a rare peritoneal
      surface malignancy diagnosis and to participate to the registry. Data will be evaluated
      within regular time frames, focusing on types of rare peritoneal surface malignancies,
      treatment modalities and patient outcomes (e.g. survival, recurrence), thereby contributing
      to the better understanding of these rare cancers.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>October 2010</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <target_duration>8 Years</target_duration>
  <primary_outcome>
    <measure>Incidence of rare peritoneal surface malignancies</measure>
    <time_frame>year 5</time_frame>
    <description>Collect detailed clinical and histological diagnosis for estimating annual incidence rate</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Impact of specific treatment strategies</measure>
    <time_frame>year 5</time_frame>
    <description>Collect detailed therapeutic strategies (surgical procedure, chemotherapy, etc.) on patients with rare peritoneal surface malignancies</description>
  </secondary_outcome>
  <number_of_groups>7</number_of_groups>
  <enrollment type="Actual">2171</enrollment>
  <condition>Rare Peritoneal Surface Malignancies</condition>
  <condition>Pseudomyxoma Peritonei</condition>
  <condition>Peritoneal Mesothelioma</condition>
  <condition>Desmoplastic Small Round Cell Tumor</condition>
  <condition>Psammocarcinoma</condition>
  <condition>Primary Peritoneal Serous Carcinoma</condition>
  <condition>Diffuse Peritoneal Leiomyomatosis</condition>
  <condition>Appendiceal Mucinous Neoplasms</condition>
  <arm_group>
    <arm_group_label>pseudomyxoma peritonei</arm_group_label>
    <description>Data from pseudomyxoma peritonei cases will be used to generate descriptive statistics on demographics, clinical characteristics including prevalence and incidence of co-morbidities, treatment patterns, and patient outcomes (resulting from treatment or disease).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>peritoneal mesothelioma</arm_group_label>
    <description>Data from peritoneal mesothelioma cases will be used to generate descriptive statistics on demographics, clinical characteristics including prevalence and incidence of co-morbidities, treatment patterns, and patient outcomes (resulting from treatment or disease).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>desmoplastic small round cell tumor</arm_group_label>
    <description>Data from desmoplastic small round cell tumor cases will be used to generate descriptive statistics on demographics, clinical characteristics including prevalence and incidence of co-morbidities, treatment patterns, and patient outcomes (resulting from treatment or disease).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>psammocarcinoma</arm_group_label>
    <description>Data from primary peritoneal serous carcinoma cases will be used to generate descriptive statistics on demographics, clinical characteristics including prevalence and incidence of co-morbidities, treatment patterns, and patient outcomes (resulting from treatment or disease).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>primary peritoneal serous carcinoma</arm_group_label>
    <description>Data from primary peritoneal serous carcinoma cases will be used to generate descriptive statistics on demographics, clinical characteristics including prevalence and incidence of co-morbidities, treatment patterns, and patient outcomes (resulting from treatment or disease).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>diffuse peritoneal leiomyomatosis</arm_group_label>
    <description>Data from diffuse peritoneal leiomyomatosis cases will be used to generate descriptive statistics on demographics, clinical characteristics including prevalence and incidence of co-morbidities, treatment patterns, and patient outcomes (resulting from treatment or disease).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>appendiceal mucinous neoplasms</arm_group_label>
    <description>Data from appendiceal mucinous neoplasms cases will be used to generate descriptive statistics on demographics, clinical characteristics including prevalence and incidence of co-morbidities, treatment patterns, and patient outcomes (resulting from treatment or disease).</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Non interventional</intervention_name>
    <description>Data collection</description>
    <arm_group_label>pseudomyxoma peritonei</arm_group_label>
    <arm_group_label>peritoneal mesothelioma</arm_group_label>
    <arm_group_label>desmoplastic small round cell tumor</arm_group_label>
    <arm_group_label>psammocarcinoma</arm_group_label>
    <arm_group_label>primary peritoneal serous carcinoma</arm_group_label>
    <arm_group_label>diffuse peritoneal leiomyomatosis</arm_group_label>
    <arm_group_label>appendiceal mucinous neoplasms</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Prospectively or retrospectively diagnosed patients with rare peritoneal surface
        malignancies.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients are eligible if they have a histologically proven rare peritoneal surface
             malignancy.

        Exclusion Criteria:

          -  Histological diagnostic of peritoneal surface malignancy not confirmed

          -  Expected clinical follow up data not available
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>François-Noël GILLY, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospices Civils de Lyon - Centre Hospitalier Lyon Sud - Service de Chirurgie Générale et Digestive - 165 chemin du grand Revoyet, PIERRE-BENITE, FRANCE, 69495</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Institut de Cancérologie de l'Ouest - Paul Papin</name>
      <address>
        <city>Angers</city>
        <zip>49100</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Jean Minjoz</name>
      <address>
        <city>Besancon</city>
        <zip>25030</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institut Bergonié</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre François Baclesse</name>
      <address>
        <city>Caen</city>
        <zip>14076</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Estaing</name>
      <address>
        <city>Clermont-ferrand</city>
        <zip>63003</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Jean Perrin</name>
      <address>
        <city>Clermont-ferrand</city>
        <zip>63011</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>AP-HP Louis MOURIER</name>
      <address>
        <city>Colombes</city>
        <zip>92700</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Bocage</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU A. Michallon</name>
      <address>
        <city>La Tronche</city>
        <zip>38700</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Oscar Lambret</name>
      <address>
        <city>Lille</city>
        <zip>59020</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHRU Claude Huriez</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Léon Bérard</name>
      <address>
        <city>Lyon</city>
        <zip>69008</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institut Paoli Calmettes</name>
      <address>
        <city>Marseille</city>
        <zip>13273</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital La Timône</name>
      <address>
        <city>Marseille</city>
        <zip>13385</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institut du Cancer Montpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34298</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Nantes Hôtel-Dieu</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU L'Archet II</name>
      <address>
        <city>Nice</city>
        <zip>06200</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>AP-HP Lariboisière</name>
      <address>
        <city>Paris Cedex 10</city>
        <zip>75475</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>AP-HP Hôpîtal Europeen Georges Pompidou</name>
      <address>
        <city>Paris Cedex 15</city>
        <zip>75908</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institut Curie</name>
      <address>
        <city>Paris</city>
        <zip>75005</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>AP-HP St Antoine</name>
      <address>
        <city>Paris</city>
        <zip>75012</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>AP-HP La Pitié-Salpêtrière</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospices Civils de Lyon - Centre Hospitalier Lyon Sud - Service de Chirurgie Générale et Digestive - 165 chemin du grand Revoyet,</name>
      <address>
        <city>Pierre-benite</city>
        <zip>69495</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Poitiers</name>
      <address>
        <city>Poitiers</city>
        <zip>86021</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Robert Debré</name>
      <address>
        <city>Reims</city>
        <zip>51092</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Charles Nicolle</name>
      <address>
        <city>Rouen</city>
        <zip>ROUEN</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institut Cancérologie de l'Ouest - René Gauducheau</name>
      <address>
        <city>Saint Herblain</city>
        <zip>44805</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Nord</name>
      <address>
        <city>St Etienne</city>
        <zip>42055</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHRU Hautepierre</name>
      <address>
        <city>Strasbourg</city>
        <zip>67098</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institut Claudius Regaud</name>
      <address>
        <city>Toulouse</city>
        <zip>31052</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Purpan</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institut de Cancérologie de Lorraine</name>
      <address>
        <city>Vandoeuvre-les-nancy</city>
        <zip>54519</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institut Gustave Roussy</name>
      <address>
        <city>Villejuif</city>
        <zip>94805</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <link>
    <url>http://www.renape-online.fr/</url>
  </link>
  <link>
    <url>https://epidemiologie-france.aviesan.fr/fr/epidemiologie-france/fiches/registre-national-des-tumeurs-rares-du-peritoine</url>
  </link>
  <link>
    <url>http://www.orpha.net/consor/cgi-bin/Clinics_Networks.php?lng=EN&amp;data_id=81899&amp;title=RENAPE---reseau-INCA-des-centres-experts-des-cancers-rares-du-peritoine&amp;search=Disease_Search_Simple</url>
  </link>
  <link>
    <url>http://www.e-cancer.fr/Professionnels-de-sante/L-organisation-de-l-offre-de-soins/Prise-en-charge-des-cancers-rares/Une-organisation-en-centres-experts</url>
  </link>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 30, 2016</study_first_submitted>
  <study_first_submitted_qc>July 12, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 15, 2016</study_first_posted>
  <last_update_submitted>August 18, 2017</last_update_submitted>
  <last_update_submitted_qc>August 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Rare peritoneal surface malignancies</keyword>
  <keyword>pseudomyxoma peritonei</keyword>
  <keyword>peritoneal mesothelioma</keyword>
  <keyword>desmoplastic small round cell tumor</keyword>
  <keyword>psammocarcinoma</keyword>
  <keyword>primary peritoneal serous carcinoma</keyword>
  <keyword>diffuse peritoneal leiomyomatosis</keyword>
  <keyword>appendiceal mucinous neoplasms</keyword>
  <keyword>registry</keyword>
  <keyword>population-based database</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Mesothelioma</mesh_term>
    <mesh_term>Desmoplastic Small Round Cell Tumor</mesh_term>
    <mesh_term>Cystadenocarcinoma, Serous</mesh_term>
    <mesh_term>Pseudomyxoma Peritonei</mesh_term>
    <mesh_term>Leiomyomatosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

